Evome Medical Technologies, Inc. Operating Income
Evome Medical Technologies, Inc. reported Operating Income of -CAD 5.52 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-04-16
- Evome Medical Technologies, Inc. operating income (loss) for the quarter ending 2023-12-31 was -1.32M CAD.
- Evome Medical Technologies, Inc. operating income (loss) for the quarter ending 2023-09-30 was -1.02M CAD.
- Evome Medical Technologies, Inc. operating income (loss) for the quarter ending 2023-06-30 was -2.49M CAD.
- Evome Medical Technologies, Inc. operating income (loss) for the quarter ending 2023-03-31 was -696.00K CAD, a 346.13% decline year-over-year.
- Evome Medical Technologies, Inc. operating income (loss) for fiscal 2023 was -5.52M CAD.
- Evome Medical Technologies, Inc. operating income (loss) for fiscal 2022 was -607.95K CAD.
- Evome Medical Technologies, Inc. operating income (loss) for fiscal 2021 was -1.02M CAD.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 10 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-12-31 | -1.32M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -2.34M CAD derived: sum of 2 quarters · filed 2024-04-16 | -4.83M CAD derived: sum of 3 quarters · filed 2024-04-16 | -5.52M CAD 10-K · filed 2024-04-16 | ||
| 2023-09-30 | -1.02M CAD 10-Q · filed 2023-11-14 | -3.50M CAD derived: sum of 2 quarters · filed 2023-11-14 | -4.20M CAD 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | -2.49M CAD 10-Q · filed 2023-08-14 | -3.19M CAD 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -696.00K CAD 10-Q · filed 2023-05-15 | |||||
| 2022-12-31 | -2.65M CAD 10-K · filed 2024-04-16 | |||||
| 2022-11-30 | -540.65K CAD 10-Q · filed 2023-01-17 | 18.98K CAD 10-Q · filed 2023-01-17 | ||||
| 2022-09-30 | -719.31K CAD 10-Q · filed 2023-11-14 | -715.98K CAD 10-Q · filed 2023-11-14 | ||||
| 2022-08-31 | -309.95K CAD 10-Q · filed 2022-10-17 | 559.63K CAD 10-Q · filed 2022-10-17 | ||||
| 2022-06-30 | -279.45K CAD 10-Q · filed 2023-08-14 | 3.33K CAD 10-Q · filed 2023-08-14 | ||||
| 2022-05-31 | 765.80K CAD 10-Q · filed 2022-07-15 | |||||
| 2022-03-31 | 282.78K CAD 10-Q · filed 2023-05-15 | |||||
| 2022-02-28 | -427.51K CAD derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03 | -417.47K CAD derived: sum of 2 quarters · filed 2023-04-03 | -317.14K CAD derived: sum of 3 quarters · filed 2023-04-03 | -607.95K CAD 10-KT · filed 2023-04-03 | 233.82K CAD 10-K · filed 2022-05-31 | |
| 2021-12-31 | -1.16M CAD 10-KT · filed 2023-04-03 | |||||
| 2021-11-30 | 10.04K CAD 10-Q · filed 2023-01-17 | 110.37K CAD derived: sum of 2 quarters · filed 2023-01-17 | -180.44K CAD 10-Q · filed 2023-01-17 | -673.92K CAD derived: sum of 4 quarters · filed 2023-01-17 | ||
| 2021-08-31 | 100.33K CAD 10-Q · filed 2022-10-17 | -190.48K CAD 10-Q · filed 2022-10-17 | -683.97K CAD derived: sum of 3 quarters · filed 2022-10-17 | -738.28K CAD derived: sum of 4 quarters · filed 2022-10-17 | ||
| 2021-05-31 | -290.81K CAD 10-Q · filed 2022-07-15 | -784.29K CAD derived: sum of 2 quarters · filed 2022-07-15 | -838.61K CAD derived: sum of 3 quarters · filed 2022-07-15 | -1.12M CAD derived: sum of 4 quarters · filed 2022-07-15 | ||
| 2021-02-28 | -493.49K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | -547.80K CAD derived: sum of 2 quarters · filed 2022-05-31 | -828.99K CAD derived: sum of 3 quarters · filed 2022-05-31 | -1.02M CAD 10-K · filed 2022-05-31 | ||
| 2020-11-30 | -54.31K CAD 10-Q · filed 2022-01-14 | -335.50K CAD derived: sum of 2 quarters · filed 2022-01-14 | -530.34K CAD 10-Q · filed 2022-01-14 | |||
| 2020-08-31 | -281.18K CAD 10-Q · filed 2021-10-15 | -476.03K CAD 10-Q · filed 2021-10-15 | ||||
| 2020-05-31 | -194.85K CAD 10-Q/A · filed 2021-08-02 |